Back to News
Market Impact: 0.1
Entera Bio Ltd. Appoints Dr. Juan Camilo Arjona Ferreira to Board of Directors
Source: Nasdaq
Management & Governance
On October 27, 2026, Entera Bio Ltd.'s board appointed Juan Camilo Arjona Ferreira, M.D., as a Class II director, effective December. The article does not specify the December year or provide further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ENTX0.10
More News
- The big takeaways and big questions from Anthropic’s S-1
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- UPS Raises Outlook as CEO Plans to Stay On to Oversee Union Talks
- Walmart says AI training is boosting confidence with the technology among its 2.1 million associates
- HSBC reports third-quarter pretax profit in line with estimates on net income boost
- How is P&G’s CEO getting inflation-weary shoppers to pay more? It starts with cashmere-like diapers